Ken Griffin’s flagship hedge fund at Citadel climbs 15.1% in 2024

Ken Griffin’s flagship hedge fund at Citadel climbs 15.1% in 2024


Ken Griffin, Founder and C.E.O. of Citadel speaks during the New York Times annual DealBook summit at Jazz at Lincoln Center on December 04, 2024 in New York City.
Michael M. Santiago | Getty Images

Billionaire investor Ken Griffin’s handful of hedge funds at Citadel all posted double-digit returns in 2024, led by its tactical trading strategy.

Citadel’s multistrategy Wellington fund, its largest, finished the year up 15.1%, according to a person familiar with the returns. All five strategies used in the flagship fund — commodities, equities, fixed income, credit and quantitative — were positive for the year, the person said.

The Miami-based firm’s tactical trading fund was the standout performer with a 22.3% return for 2024, the person said. Citadel’s equity fund returned roughly 18%, while its global fixed income strategy gained 9.7% last year.

Citadel declined to comment. The hedge fund giant had $66 billion in assets under management as of December.

The stock market just closed out a banner year with the S&P 500 surging 23.3%, building on a gain of 24.2% in 2023. The two-year gain of 53% is the best since the nearly 66% rally in 1997 and 1998.

Griffin recently criticized the steep tariffs President-elect Donald Trump has vowed to implement, saying crony capitalism could be a consequence.

The CEO also said he’s not focused on taking Citadel Securities public in the foreseeable future. The securities firm is a Miami-based market maker founded by the 56-year-old Florida native in 2002.



Source

Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more
Finance

Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more

Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an experimental flu shot, mRNA-1010. Moderna said it has requested a meeting with the FDA to “understand the path forward.” Humana — The health insurance company […]

Read More
Crypto’s ‘age of speculation’ may be over, says Galaxy CEO Mike Novogratz
Finance

Crypto’s ‘age of speculation’ may be over, says Galaxy CEO Mike Novogratz

Key Points Bitcoin is down more than 21% so far this year, and nearly 50% from its peak in October. Galaxy CEO Mike Novogratz said crypto’s “age of speculation,” where investors expected outsized returns, may be ending as more risk-adverse players enter the sector. “It’s going to be real world assets with much lower returns,” […]

Read More
Vatican Bank makes first foray into equity indexes, setting stage for potential ETF launches
Finance

Vatican Bank makes first foray into equity indexes, setting stage for potential ETF launches

Key Points The Vatican Bank launched on Tuesday two equity indexes tracking stocks that it said are consistent with Catholic ethical principles. Its Eurozone fund includes semiconductor supplier ASML Holding and telecommunications company Deutsche Telekom, while the US-based index holds Meta and Amazon, among other stocks.   The debut sets up the possibility of licensing […]

Read More